FDA Drug Application (203901) for DEXTROAMPHETAMINE SULFATE by ACTAVIS ELIZABETH

Back to FDA Applications sponsored by ACTAVIS ELIZABETH

Application Number203901
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDEXTROAMPHETAMINE SULFATE
Active IngredientDEXTROAMPHETAMINE SULFATE

Active IngredientCount
List of drugs with Active Ingredient DEXTROAMPHETAMINE SULFATE22


Back to FDA Applications sponsored by ACTAVIS ELIZABETH